Results Introduction There are social inequalities in breast cancer survival with those in more deprived and Black ethnic groups having lower survival.

Slides:



Advertisements
Similar presentations
The National Cancer Intelligence Network An overview Professor David Forman Professor of Cancer Epidemiology, University of Leeds NCIN – Lead for Information.
Advertisements

Prognostic factors for breast cancer survival in affluent and deprived areas Jasmina Stefoski-Mikeljevic.
© Cancer Research UK 2011 Registered charity in England and Wales ( ) and Scotland (SC041666) Cervical Cancer - UK December 2011 For more information.
The All Breast Cancer Report was published in October breastscreen/research.html#breast- cancer-report.
© Cancer Research UK 2011 Registered charity in England and Wales ( ) and Scotland (SC041666) Breast Cancer - UK December 2011 For more information.
Healthcare in the UK Margaret Costello – Gorlin Syndrome Group.
Breast Cancer Screening Beyond 70 Years Old Henry Kwok Breast Imaging Fellow BreastScreen Aotearoa Counties Manukau.
© Cancer Research UK 2004 Registered charity number Figure One: Five-year age-standardised relative survival (%), adults diagnosed , England.
Chronic kidney disease Mr James Hollinshead Public Health Analyst East Midlands Public Health Observatory (EMPHO) UK Renal Registry 2011 Annual Audit Meeting.
Disparities in Cancer September 22, Introduction Despite notable advances in cancer prevention, screening, and treatment, a disproportionate number.
Early Detection Is Your Best Protection. Breast Cancer Statistics for Women A woman has a one in eight chance of developing breast cancer in her lifetime.
1 Key concepts, data, methods and results Index Trends in cancer survival by ethnic and socioeconomic group, New Zealand, Soeberg M, Blakely.
Ethnic Disparities in Early Breast Cancer Management among Asian Americans and Pacific Islanders Rebecca P. Gelber, MD, MPH Department of Medicine, University.
Kathrin Strasser-Weippl 1 st Medical Department Wilhelminen Hospital, Vienna Cancer Care in Europe.
INCIDENCE AND SURVIVAL TRENDS OF COLORECTAL CANCER FROM 2002 TO 2011 BE Ansa; E Alema-Mensah; MD Claridy; JQ Sheats; B Fontenot, and SA Smith Georgia Regents.
Cancer survival in the UK and Republic of Ireland B Rachet 1, M Quinn 2, D Brewster 3, A Gavin 4, J Steward 5, H Comber 6, L Gonsalves 7, V Mak 8, MP Coleman.
HIV Mortality for Florida and the Six (EMAs) Eligible Metropolitan Areas Florida Department of Health HIV/AIDS & Hepatitis Program Death data as of 07/12/2012.
Socio-economic inequalities in the pathway of care for pancreatic cancer James Brown, Jean Adams, Martin White & Mark Pearce Institute of Health & Society.
© Cancer Research UK 2011 Registered charity in England and Wales ( ) and Scotland (SC041666) Colorectal Cancer - UK December 2011 For more information.
National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.
Breast cancer in NE London Frances Haste, Public Health lead.
What the cancer tools show for London Vivian Mak National Cancer Intelligence Network London Public Health Knowledge and Intelligence Network meeting Wednesday.
South West Public Health Observatory The changing casemix of prostate cancer patients and prostatectomies in the South West Sean McPhail.
Prostatectomy operations in England South West Public Health Observatory Trends in the use of radical prostatectomy in England Sean McPhail.
Hannah K Weir, PhD Epidemiology and Applied Research Branch North American Association of Central Cancer Registries Quebec City, Quebec, Canada June 2010.
Variation in place of death from cancer: studies in South East England Elizabeth Davies, Peter Madden, Victoria Coupland, Karen Linklater, Henrik Møller.
Evaluating the UK Breast Screening Programme Study design and practicalities Louise Johns, Sue Moss, Tony Swerdlow Department of Health Cancer Screening.
Prostate cancer and socio-economic deprivation When PCTs are ranked according to their income score using the Indices of Multiple Deprivation (IMD)* there.
UK Hospitalizations due to Stroke in Prostate Cancer Patients
Benjamin Kearns, The University of Sheffield
Age-Standardised Ten-Year Net Survival for the Most Common Cancers in Females, England and Wales, Ten-year survival for is predicted.
THE ASSOCIATION BETWEEN HAVING A LONG-TERM CONDITION AND UPTAKE OF POPULATION-BASED SCREENING FOR COLORECTAL CANCER Benjamin Kearns, The University of.
Age-Standardised Five-Year Net Survival, England and Wales
Non-Hodgkin Lymphoma (C82-C85):
All Cancers Excluding Non-Melanoma Skin Cancer (C00-C97 Excl
Stomach Cancer (C16): Net Survival up to Ten Years after Diagnosis, Adults (Aged 15-99), England and Wales Please include the citation provided.
Age-Standardised One-Year Net Survival, England and Wales
Benefit Type and Care Source in Relation to Mammography Screening and Breast Cancer Stage at Diagnosis among DoD Beneficiaries Janna Manjelievskaia1, Derek.
Bladder Cancer (C67): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-99, England & Wales 1-Year 5-Year 10-Year Survival (%) Survival.
Jane E Scullion Respiratory Nurse Consultant
Ovarian Cancer (C56 C57.0-C57.7):
A “Scottish effect” for health?
(95% confidence interval)
Segmented analysis of prostate cancer pathway from referral to treatment: This work was carried out in partnership between the Transforming.
Kidney Cancer (C64-C66 C68): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-99, England & Wales 1-Year 5-Year 10-Year Survival (%)
But how to treat those with positive SLNB? Results and Discussion
Lung Cancer (C33-C34): Age-Standardised Five-Year Net Survival, England and Wales Please include the citation provided in our Frequently Asked.
Prevention and Early Diagnosis of Cancer Ongar Health Centre Patient Forum 7th March 2018 Sue White Cancer Research UK Facilitator.
Treatment breakdown for NSCLC cancers
Treatment breakdown for salivary gland cancers
Treatment breakdown for larynx cancers
Treatment breakdown for stomach cancers
Segmented analysis of the lung cancer median pathway from referral to treatment: This work was carried out in partnership between the Transforming.
Treatment breakdown for bladder cancers
Brain Cancer (C71): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-99, England & Wales 1-Year 5-Year 10-Year Survival (%) Survival.
Treatment breakdown for oesophagus cancers
Treatment breakdown for pancreatic cancers
Treatment breakdown for hypopharynx cancers
All Cancers Excluding Non-Melanoma Skin Cancer (C00-C97 Excl
Treatment breakdown for ovary cancers
(95% confidence interval)
Brain Cancer (C71): Age-Standardised Five-Year Net Survival, England and Wales Please include the citation provided in our Frequently Asked Questions.
Treatment breakdown for other head and neck cancers
Megan Eguchi, MPh Sana karam, md, phd
All Cancers Excluding Non-Melanoma Skin Cancer (C00-C97 Excl
UK Renal Registry 12th Annual Report
Brain Cancer (C71): Net Survival up to Ten Years after Diagnosis, Adults (Aged 15-99), England and Wales Please include the citation provided.
Colorectal cancer survival disparities in California
Dataset Description Time Period Accident & Emergency
Representativeness of linked cancer registry and dispensed prescription data as compared with cancer registry data alone, by key patient and tumour characteristics.
Presentation transcript:

Results Introduction There are social inequalities in breast cancer survival with those in more deprived and Black ethnic groups having lower survival. These differences might be smaller when the cancer is screen-detected. We used linked data and new analytic techniques to investigate survival differences amongst women with screen-detected and non-screen-detected breast cancer, by ethnicity and deprivation. Conclusions There was a heartening lack of difference in net survival from breast cancer between the three main ethnic groups. Screening conferred a survival benefit to all but there were still wide disparities in survival by deprivation. Further research should examine how much of the observed socio-economic survival differentials are explained by later diagnosis, and how much by less effective post-diagnostic management. At five years, there was a 16% difference in survival between the less deprived women whose cancer was screen-detected (94.1%) and the more deprived women whose cancer was not screen-detected (78.0%). Methods Data West Midlands Breast Screening Quality Assurance Reference Centre supplied linked data from the cancer registry, National Breast Screening Service, Hospital Episode Statistics and ONS: ­ tumour factors (stage, morphology) ­ patient characteristics (age, deprivation, ethnicity) ­ treatment ­ screening history ­ inpatient stays up to 18 months before diagnosis ­ vital status, date of death Cohort 20,283 women diagnosed with breast cancer, aged 50 to 70 years ­ continuously eligible for screening ­ diagnosed between 1989 and 2011, followed up to 2012 ­ ethnicity 90% complete, last 10% imputed using name recognition software Analyses Net survival ­ estimated using ‘stns’ command in STATA ­ corrected for expected survival with deprivation- and ethnic-specific life tables Estimates adjusted for lead-time bias and overdiagnosis Project funded by the National Awareness and Early Diagnosis Initiative: a partnership between Cancer Research UK; Department of Health England; Economic and Social Research Council; Health & Social Care Research and Development Division, Pubic Health Agency, Northern Ireland; National Institute for Social Care and Health Research, Wales; and the Scottish Government. Confidence intervals (shaded areas) are shown for illustration in the first graph. Where they fully overlap, it shows that there is no statistical difference between the groups. They are omitted from subsequent graphs in which they fully overlap, for clarity. Little evidence was found for differences in survival by ethnic group, and by extent of disease:Screening gave a similar survival benefit to all women, regardless of their ethnic group: There was a clear difference in survival by deprivation. This was evident for both screen-detected and non-screen-detected women. The survival gaps widen with longer survival times. Contact: Ethnicity, deprivation and screening: an analysis of survival from breast cancer in the West Midlands Melanie Morris 1, Laura M Woods 1, Nicola Rogers 2, Emma O’Sullivan 2, Olive Kearins 2, Bernard Rachet 1 1 Cancer Research UK Cancer Survival Group | London School of Hygiene & Tropical Medicine | London | 2 West Midlands Breast Screening Quality Assurance Reference Centre, Public Health England Melanie Morris 1, Laura M Woods 1, Nicola Rogers 2, Emma O’Sullivan 2, Olive Kearins 2, Bernard Rachet 1 1 Cancer Research UK Cancer Survival Group | London School of Hygiene & Tropical Medicine | London | 2 West Midlands Breast Screening Quality Assurance Reference Centre, Public Health England